Nuvation Bio
NUVB
4.86
-0.02
-0.41%
Nuvation Bio
US · NUVB
#2898 by market cap
Listed 1970
4.86
-0.02
-0.41%
Live - 5344 symbols - heartbeat 375s ago
· 2026-10-08 08:26
Pre-market
4.81
-1.06%
After-hours
4.95
+1.85%
Overnight
4.82
-0.82%
- Market cap
- 1.71B
- P/E (TTM)i
- -11.05
- P/Bi
- 6.72
- EPSi
- -0.60
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on NUVB?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy RatingMarket Newswire · 2026/9/15
-
Rating change
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13Market Newswire · 2026/8/7
-
Rating change
B. Riley Securities Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $14Market Newswire · 2026/8/7
-
Rating change
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $19Market Newswire · 2026/7/7
-
Rating change
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/7/21
-
Rating change
H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)TipRanks · 2026/5/27
-
Citi Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/10/2
-
Rating change
A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $20Market Newswire · 2026/5/5
-
Rating change
Cantor Fitzgerald Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12Market Newswire · 2026/8/21
-
Rating change
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $21Market Newswire · 2026/7/27
-
Citi Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12Market Newswire · 2026/9/30
-
Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $11Market Newswire · 2026/9/15
-
Rating change
JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/7/22
-
Rating change
A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $21Market Newswire · 2026/8/7
-
Rating change
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21Market Newswire · 2026/7/28
-
J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
J.P. Morgan Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13Market Newswire · 2026/8/18
-
Rating change
Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 2026/9/15
-
Rating change
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2026/5/27
-
Rating change
TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy RatingMarket Newswire · 2026/6/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:26:01 · For reference only, not investment advice and not tailored to your situation.